Oncology Practice Management Issues

August 2016, Vol 6, No 8

Recent Drugs and Diagnostics Approved by the FDA

FDA News

In This Article First Liquid Biopsy Approved for Diagnosing EGFR Mutations in NSCLC FDA Approves Axumin Imaging Agent for Recurrent Prostate Cancer Tecentriq Approved for Metastatic Bladder Cancer Afatinib Receives New Indication for Advanced Squamous-Cell NSCLC This section provides updates [ Read More ]